HaplnScience, Inc. is a bio-venture company established in late 2018
with the aim to develop fundamental treatments for aging-related diseases.
We will contribute to the health and well-being of humankind by restoring the damaged or
degenerated tissue with aging through research on the unique mechanism of ‘rhHAPLN1’
and its development as a breakthrough anti-aging therapy.